Reuters logo
BRIEF-Concert pharmaceuticals announces $30 million venture debt financing from hercules capital
June 12, 2017 / 11:18 AM / 3 months ago

BRIEF-Concert pharmaceuticals announces $30 million venture debt financing from hercules capital

June 12 (Reuters) - Concert Pharmaceuticals Inc

* Concert pharmaceuticals announces $30 million venture debt financing from Hercules Capital

* Continue to expect to realize $160 million in connection with closing of CTP-656 asset purchase agreement with Vertex Pharmaceuticals

* Debt is in form of a secured loan, secured by concert’s assets, excluding intellectual property, and bearing interest of 8.55 pct

* Loan will mature on June 1, 2021 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below